NEVOLA, RICCARDO
 Distribuzione geografica
Continente #
EU - Europa 2.609
AS - Asia 1.271
NA - Nord America 865
SA - Sud America 185
AF - Africa 15
OC - Oceania 1
Totale 4.946
Nazione #
RU - Federazione Russa 2.029
US - Stati Uniti d'America 830
SG - Singapore 405
CN - Cina 274
IT - Italia 245
VN - Vietnam 214
HK - Hong Kong 167
BR - Brasile 155
IE - Irlanda 105
DE - Germania 77
KR - Corea 68
IN - India 48
JP - Giappone 37
FR - Francia 22
NL - Olanda 22
GB - Regno Unito 21
FI - Finlandia 20
CA - Canada 19
PL - Polonia 14
MX - Messico 12
AR - Argentina 9
CZ - Repubblica Ceca 9
AT - Austria 8
BD - Bangladesh 8
TR - Turchia 8
ES - Italia 7
CO - Colombia 6
ID - Indonesia 6
BE - Belgio 5
EC - Ecuador 5
MA - Marocco 5
PT - Portogallo 5
IQ - Iraq 4
LT - Lituania 4
UA - Ucraina 4
ZA - Sudafrica 4
BO - Bolivia 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
HR - Croazia 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
MO - Macao, regione amministrativa speciale della Cina 2
NP - Nepal 2
PK - Pakistan 2
SE - Svezia 2
TH - Thailandia 2
TW - Taiwan 2
UY - Uruguay 2
UZ - Uzbekistan 2
AL - Albania 1
AU - Australia 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
LY - Libia 1
MD - Moldavia 1
OM - Oman 1
PE - Perù 1
PY - Paraguay 1
RO - Romania 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
VE - Venezuela 1
Totale 4.946
Città #
Moscow 728
Singapore 190
Hong Kong 163
San Jose 143
Dublin 104
Hefei 81
Santa Clara 78
Naples 69
Ashburn 67
Ho Chi Minh City 67
Seoul 67
The Dalles 64
New York 54
Hanoi 52
Chandler 45
Bengaluru 37
Munich 33
Dallas 26
Beijing 24
Los Angeles 19
Amsterdam 18
Da Nang 16
São Paulo 14
Frankfurt am Main 12
Helsinki 12
Boardman 10
Florence 10
Haiphong 10
Orem 10
Milan 9
Chicago 8
Falkenstein 8
Montreal 8
Warsaw 8
Bremen 7
Cambridge 7
Guastalla 7
Liveri 7
Rome 7
Atlanta 6
Hillsboro 6
London 6
Princeton 6
Roxbury 6
Belo Horizonte 5
Brussels 5
Ercolano 5
Lappeenranta 5
Nuremberg 5
Paris 5
Thái Nguyên 5
Tokyo 5
Bexley 4
Boston 4
Brooklyn 4
Chennai 4
Hải Dương 4
Istanbul 4
Mexico City 4
Mumbai 4
Prague 4
Shanghai 4
Toronto 4
Ankara 3
Aversa 3
Baghdad 3
Beaverton 3
Boydton 3
Brasília 3
Brno 3
Can Tho 3
Casablanca 3
Dhaka 3
Eboli 3
La Paz 3
Phủ Lý 3
Quito 3
Quận Bình Thạnh 3
Salerno 3
Salvador 3
San Francisco 3
Seattle 3
Secaucus 3
Shenzhen 3
Tianjin 3
Turku 3
Vienna 3
Wroclaw 3
Yên Bái 3
Afragola 2
Araguatins 2
Baku 2
Banda Aceh 2
Barlassina 2
Biên Hòa 2
Bonea 2
Brdo 2
Buenos Aires 2
Buffalo 2
Bắc Ninh 2
Totale 2.513
Nome #
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 194
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 179
Non-invasive respiratory support in SARS-CoV-2 related acute respiratory distress syndrome: when is it most appropriate to start treatment? 175
Epidemiology of HCV and HBV in a High Endemic Area of Southern Italy: Opportunities from the COVID-19 Pandemic—Standardized National Screening or One Tailored to Local Epidemiology? 164
Predictors of in-hospital mortality of COVID-19 patients and the role of telemetry in an internal medicine ward during the third phase of the pandemic 164
Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease 162
COVID-19 and arrhythmia: The factors associated and the role of myocardial electrical impulse propagation. An observational study based on cardiac telemetric monitoring 159
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 155
HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis 152
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 152
Factors affecting long-term changes of liver stiffness in direct-acting anti-hepatitis C virus therapy: a multicenter prospective study 151
Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19 151
Remdesivir plus dexamethasone versus dexamethasone alone for the treatment of COVID-19 patients requiring supplemental O2 therapy: a prospective controlled non-randomized study 147
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives 140
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 138
Predictors of early and late hepatocellular carcinoma recurrence 135
Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era? 135
Long-Term Prognosis among COVID-19 Patients: The Predictive Role Played by Hyperinflammation and Arrhythmic Disorders in Fatal Outcome 134
Directly acting antiviral-based treatment for hcv-infected persons who inject drugs: A multicenter real-life study 133
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma 132
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 131
Sodium-Glucose Co-Transporters Family: Current Evidence, Clinical Applications and Perspectives 129
Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination 128
Metabolic dysfunction-associated steatotic liver disease (MASLD): a systemic disease with a variable natural history and challenging management 126
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 126
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 125
Liver Involvement during SARS-CoV-2 Infection Is Associated with a Worse Respiratory Outcome in COVID-19 Patients 123
Alcohol Consumption and Liver Metabolism in the Era of MASLD: Integrating Nutritional and Pathophysiological Insights 122
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 122
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies 115
Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals 113
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 110
The Cross-Talk Between the Heart and the Liver: The Involvement of the Mitral Valve as a Novel Actor upon the Ancient Scene of Liver Cirrhosis 92
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis 90
Metabolic Rewiring of Bacterial Pathogens in Response to Antibiotic Pressure—A Molecular Perspective 85
Multidrug-Resistant Infections and Metabolic Syndrome: An Overlooked Bidirectional Relationship 84
The transition from NAFLD to MASLD: implications for Diagnosis, Prognosis, and Clinical Management 75
The Intestinal Thread of Fate: How the Microbiota Shapes the Story of Liver Disease 59
Totale 5.007
Categoria #
all - tutte 14.413
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.413


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202256 0 0 0 1 3 0 2 1 5 17 5 22
2022/2023250 10 3 13 14 30 30 2 14 95 14 14 11
2023/2024288 29 9 20 36 49 54 3 7 4 14 23 40
2024/2025785 7 15 15 21 127 54 81 76 152 81 79 77
2025/20263.628 196 247 228 147 342 1.861 250 143 140 74 0 0
Totale 5.007